Feed ORINY
OR

Orion Oyj ORINY · OTC

$53.25 +4.56% (+$2.32)

Market cap
24.8B €
Enterprise value
24.8B €
P/E
42.2x
Forward P/E
19.2x
PEG
1.1x
P/S
12.1x
P/FCF
64.4x
EV/EBITDA
31.6x
ROIC
40.6%
Bruto marža
65.9%
Neto marža
28.5%
Dividend yield
2.07%
Payout ratio
87.2%
Neto dolg/EBITDA
0.0x
Beta
0.29
Free float
44.0%

O podjetju

Orion Oyj is a Finnish pharmaceutical company headquartered in Espoo, focused on the research, development, manufacturing, and distribution of medicines and healthcare products. The company specializes in treatments for neurological and respiratory diseases, oncology, and urological disorders, while also offering a wide range of generic medicines and veterinary products. Orion operates not only in Finland but also internationally, in collaboration with various global partners. The company is recognized for its long-standing scientific heritage, high-quality standards, and strong focus on innovations that enhance patients’ quality of life.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Aino Anna Liisa Hurme

Employees

4,029

Headquarters

Espoo

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.